Skip to main content
. 2016 Sep 29;8(4):7025–7038. doi: 10.18632/oncotarget.12347

Table 1. Demographic and clinicopathological characteristics of patients included in the study.

HP SSA/P TA p-value
(n= 33) (n= 39) (n= 36)
Gender Female 17 (52%) 22 (56%) 18 (50%) 0.93
Male 11 (33%) 15 (39%) 14 (39%)
Unknown 5 (15%) 2 (5%) 4 (11%)
Age Median (Range) 59 (50-91) 60 (28-77) 61 (47-84) 0.9
Ethnicity African American 6 (18%) 2 (5%) 3 (8%) 0.19
Caucasian 20 (61%) 30 (77%) 24 (67%)
Hispanic 0 (0%) 0 (0%) 1 (3%)
Asian 0 (0%) 1 (3%) 0 (0%)
Unknown 7 (21%) 6 (15%) 8 (22%)
Polyp site Cecum 0 (0%) 4 (10%) 4 (11%) 0.025
Ascending 2 (6%) 10 (26%) 10 (28%)
Transverse 1 (3%) 6 (15%) 6 (17%)
Descending 4 (12%) 5 (13%) 3 (8%)
Sigmoid 10 (30%) 7 (18%) 4 (11%)
Rectum 9 (27%) 5 (13%) 5 (14%)
Unknown 7 (21%) 2 (5%) 4 (11%)
Family History of colon cancer No 18 (55%) 29 (74%) 27 (75%) 0.34
Yes 7 (21%) 6 (15%) 4 (11%)
Unknown 8 (24%) 4 (10%) 5 (14%)
Tobacco No 6 (18%) 13 (33%) 10 (28%) 0.5
Yes 20 (61%) 22 (57%) 21 (58%)
Unknown 7 (21%) 4 (10%) 5 (14%)
Polyp size (cm3) Mean (SD) 0.048 (0.084) 0.101 (0.168) 0.088 (0.174) 0.41
Number of polyps Median (range) 2 (1-7) 2 (1-7) 3 (1-7) 0.018
Prior or subsequent colonoscopies with polyps Median (range) 1 (1-3) 3 (0-5) 1 (0-3) 0.28

HP, hyperplastic polyp; SSA/Ps, sessile serrated adenoma/polyp; TA, tubular adenoma